Novartis AG

Roche Holding AG

Amgen Inc.

Companies will get a three-year reprieve from pharmaceutical duties, provided they invest in manufacturing within the U.S.

Nine major pharma companies have made deals with Trump to lower drug prices

Other drug manufacturers may also join the list of companies for the price deal

U.S. to reach drug pricing agreements with Novartis and Roche - Bloomberg

AstraZeneca PLC

Apple Inc.

QUALCOMM Incorporated

Snap Inc.

AppLovin Corporation

Rivian Automotive, Inc.

Tesla, Inc.

DoorDash, Inc.

Daily review and forecast of events on the U.S. stock market from Mikhail Denislamov, Deputy Director of Freedom Capital Markets Research.

Morning in New York: Fed rhetoric and corporate reporting in focus

Daiichi Sankyo Company, Limited

The Enhertu drug was found to be more effective than a drug from Swiss Roche

AstraZeneca's drug has produced positive results in the fight against breast cancer. What about the stock?

Anglo-Swedish pharmaceutical concern AstraZeneca will float shares on the New York Stock Exchange, it <a href="https://news.cision.com/se/astrazeneca/r/astrazeneca-to-harmonise-its-listing-structure-across-the-london-stock-exchange--nasdaq-stockholm-an%2Cc4241238?utm_source=chatgpt.com">said </a>Monday, Sept. 29. These securities will replace depositary receipts, which are now traded on the Nasdaq exchange.

AstraZeneca to float in New York but retain London listing

Novo Nordisk A/S

European pharma giants have a chance to avoid prohibitive duties on branded drugs, says JPMorgan Chase

Pharma stocks in Europe reacted weakly to Trump's threats of new duties

The Coca-Cola Company

Chewy, Inc.

Eli Lilly and Company

Steve Cohen, founder of hedge fund Point72 Asset Management, believes the current upturn in the markets looks unreliable. He estimates the likelihood of a recession at nearly 45%, and he says indexes could yet return to April lows. "We're all somewhat dependent on news right now, and that's a tricky way to manage money," the investor says.

Cohen's Shield: 10 stocks the Point72 founder uses to protect his portfolio from overheating

Pfizer Inc.

The US President sent letters to 17 pharmaceutical market leaders

Pharma stocks plummet after Trump's demand for price cuts. Should we be worried?

The owner of Figma, an online editor for creating websites and mobile applications that Adobe tried to buy for $20 billion, may launch an IPO as early as July. Surgical imaging software developer Brainlab has postponed its first major IPO of 2025 in Germany. AstraZeneca, the UK's most expensive public company, is thinking of moving its listing from London to the US. The main IPO market events of the week are in our selection.

A Google supplier and a startup missed by Adobe are going public: what's important about the IPO by July 6

At least a dozen companies are looking for a way to reduce muscle mass loss when taking weight loss drugs